2023
Pre-exposure prophylaxis service among men who have sex with men in Malaysia: findings from a discrete choice experiment
Dubov A, Altice F, Gutierrez J, Wickersham J, Azwa I, Kamarulzaman A, Gautam K, Shrestha R. Pre-exposure prophylaxis service among men who have sex with men in Malaysia: findings from a discrete choice experiment. Scientific Reports 2023, 13: 14200. PMID: 37648731, PMCID: PMC10468492, DOI: 10.1038/s41598-023-41264-5.Peer-Reviewed Original ResearchConceptsInjectable PrEPPre-exposure prophylaxis servicesDaily oral PrEPPre-exposure prophylaxisMalaysian MSMPrEP deliveryOral PrEPPrEP uptakeMSMPrEPLatent class analysisDiscrete choice experimentMenDelivery preferencesDelivery programsSexGroupClass analysisType of programPreference groupsOnline surveyProphylaxisInitiation rateHIVDosing
2018
Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment
Dubov A, Ogunbajo A, Altice FL, Fraenkel L. Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment. AIDS Care 2018, 31: 545-553. PMID: 30554519, PMCID: PMC6408226, DOI: 10.1080/09540121.2018.1557590.Peer-Reviewed Original ResearchConceptsYoung MSMInjectable PrEPPrEP uptakeUptake of PrEPPre-exposure prophylaxisHigh HIV burdenMSM of colorMSM preferencesPrEP administrationDaily PrEPPrEP initiationHIV burdenDemand PrEPConsultation visitMSMPrEP programPrEPLatent class analysisDelivery programsMenGroupClass analysisStructural barriersLow levelsUptakeExtended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community
Springer SA, Di Paola A, Barbour R, Azar MM, Altice FL. Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2018, 79: 92-100. PMID: 29781884, PMCID: PMC6092223, DOI: 10.1097/qai.0000000000001759.Peer-Reviewed Original ResearchConceptsAlcohol use disorderViral suppressionExtended-release naltrexoneXR-NTXPlacebo groupPlacebo-controlled trialMonthly injectionsSecondary outcomesTreat analysisIncarcerated individualsEligible participantsWhite raceUse disordersAlcohol consumptionHIVMonthsNaltrexoneBaselineDisordersInjectionIncarcerated peopleParticipantsPlaceboGroupSuppression
2017
Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine
Dubov A, Fraenkel L, Yorick R, Ogunbajo A, Altice FL. Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine. AIDS And Behavior 2017, 22: 1100-1112. PMID: 29214409, PMCID: PMC10866617, DOI: 10.1007/s10461-017-1996-y.Peer-Reviewed Original ResearchConceptsPre-exposure prophylaxisLow self-perceived riskSelf-perceived riskInjectable PrEPMSM preferencesPrEP administrationPrEP initiationDaily PrEPHIV prevalencePatient preferencesRisk groupsRisk populationsMedical carePrEPLatent class analysisProphylaxisMenDelivery programsMSMUkrainian menProgram deliverySexGroupClass analysisSuccessful delivery
2016
Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators
Polonsky M, Rozanova J, Azbel L, Bachireddy C, Izenberg J, Kiriazova T, Dvoryak S, Altice FL. Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators. AIDS And Behavior 2016, 20: 2950-2960. PMID: 27011378, PMCID: PMC5035551, DOI: 10.1007/s10461-016-1375-0.Peer-Reviewed Original ResearchConceptsMethadone maintenance therapyGroup 1Drug useGroup 2 participantsDrug addiction severityAwareness of addictionMaintenance therapyMethadone treatmentExploration of mediatorsHIV stigmaGroup 2MMT treatmentAddiction severityGroup comparisonsDrug addictionHIVHigh rateAddictionHigher optimismDrugsTreatmentParticipantsMethadoneGroupPaper’s key findings
2012
Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners
Springer SA, Qiu J, Saber-Tehrani AS, Altice FL. Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners. PLOS ONE 2012, 7: e38335. PMID: 22719814, PMCID: PMC3365007, DOI: 10.1371/journal.pone.0038335.Peer-Reviewed Original ResearchConceptsMaximum viral suppressionOpioid dependenceViral suppressionGlobal health qualityMaximal viral suppressionHIV treatment outcomesBuprenorphine/naloxoneCopies/mLChronic relapsing diseaseDSM-IV criteriaAntiretroviral therapyOpioid useProspective trialProspective studyRelapsing diseaseOpioid dependentsTreatment outcomesHIV-1HIVNLXHealth qualityTherapyWeeksSuppressionGroup
2009
A Prospective Controlled Trial of Routine Opt-Out HIV Testing in a Men's Jail
Kavasery R, Maru DS, Sylla LN, Smith D, Altice FL. A Prospective Controlled Trial of Routine Opt-Out HIV Testing in a Men's Jail. PLOS ONE 2009, 4: e8056. PMID: 19946371, PMCID: PMC2777336, DOI: 10.1371/journal.pone.0008056.Peer-Reviewed Original ResearchConceptsRoutine optHIV testingProspective Controlled TrialTesting groupMen's jailProportion of menPreliminary positive resultsPrimary outcomeControlled TrialsJail detaineesMultivariate analysisDisease controlHIVLower likelihoodWeek periodHigh ratePositive resultsTrialsGroupMale inmatesNew HavenOptimal timeJailEarly releaseTestingRoutine Opt-Out HIV Testing Strategies in a Female Jail Setting: A Prospective Controlled Trial
Kavasery R, Maru DS, Cornman-Homonoff J, Sylla LN, Smith D, Altice FL. Routine Opt-Out HIV Testing Strategies in a Female Jail Setting: A Prospective Controlled Trial. PLOS ONE 2009, 4: e7648. PMID: 19946370, PMCID: PMC2777332, DOI: 10.1371/journal.pone.0007648.Peer-Reviewed Original ResearchConceptsRoutine optHIV testingJail settingsNew CDC guidelinesHIV testing strategiesProspective Controlled TrialLow testing ratesProportion of womenControlled TrialsPrimary outcomeCDC guidelinesHigh prevalenceTesting ratesJail detaineesYounger ageLower likelihoodHIVWeek periodHigh rateTesting groupTrialsWomenTesting strategiesFemale inmatesGroup
2007
Strategies for Primary HIV Prevention That Target Behavioral Change
Safren SA, Wingood G, Altice FL. Strategies for Primary HIV Prevention That Target Behavioral Change. Clinical Infectious Diseases 2007, 45: s300-s307. PMID: 18190303, DOI: 10.1086/522554.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV infectionHigh-risk behaviorsPrimary HIV preventionBehavioral changesNew HIV infectionsInjection drug usersRoutes of transmissionHIV transmissionImmunodeficiency virusHIV preventionDrug usersObjective evidencePsychosocial influencesInfectionOverall rateTarget populationMinority racial groupsRacial groupsMenRiskGroupVaccinePublic awarenessComplex interplay